Power Patti, Gregoire Jean, Duggan Máire, Nation Jill
Newfoundland Cancer and Treatment Research Foundation, St. John's NL.
Gynecologic Oncology Service, Centre Hospitalier Universitaire de Québec, Quebec City QC.
J Obstet Gynaecol Can. 2006 Oct;28(10):884-887. doi: 10.1016/S1701-2163(16)32280-0.
This study compared clinical outcomes associated with Pap smear reports of atypical squamous cells cannot exclude HSIL (ASC-H) and those associated with "low-grade smears containing occasional cells suggestive of HSIL" (LSIL-H). In Alberta, women with ASC-H are referred for colposcopy, and women with LSIL are managed with follow-up Pap smears. LSIL-H is not included in the Bethesda classification and has not been characterized in terms of cytological features, reporting, management, and clinical course.
All ASC-H (n = 153) and LSIL-H (n = 189) Pap smears recorded in the regional laboratory information system between December 2000 and December 2001 were identified. All available histology for each associated patient over the subsequent two&year period was reviewed to determine if a high-grade histological lesion was ever confirmed in a biopsy, loop electrosurgical excision procedure (LEEP), or hysterectomy specimen.
A high-grade squamous intraepithelial lesion was identified in 48% of the ASC-H group and 40% of the LSIL-H group (P = 0.136). Most of the HSIL histopathology was identified on the first colposcopic visit, suggesting that high-grade dysplasia may have been present at the time of the original Pap smear.
Pap smears reporting ASC-H and LSIL-H predict a high-grade squamous intraepithelial lesion with similar accuracy. Since approximately 40% of patients with an LSIL-H Pap smear have either concurrent or subsequent high-grade cervical pathology, we also recommend immediate referral for colposcopy in this group of patients.
本研究比较了非典型鳞状细胞不能排除高级别鳞状上皮内病变(ASC-H)的巴氏涂片报告以及与“含有偶尔提示高级别鳞状上皮内病变细胞的低级别涂片”(LSIL-H)相关的临床结果。在艾伯塔省,ASC-H的女性会被转诊至阴道镜检查,而LSIL的女性则通过后续巴氏涂片进行管理。LSIL-H未包含在贝塞斯达分类中,并且在细胞学特征、报告、管理和临床病程方面尚未得到描述。
确定了2000年12月至2001年12月期间区域实验室信息系统中记录的所有ASC-H(n = 153)和LSIL-H(n = 189)巴氏涂片。回顾了随后两年期间每位相关患者的所有可用组织学检查结果,以确定在活检、环形电切术(LEEP)或子宫切除标本中是否曾确诊高级别组织学病变。
ASC-H组中有48%发现高级别鳞状上皮内病变,LSIL-H组中有40%发现高级别鳞状上皮内病变(P = 0.136)。大多数高级别鳞状上皮内病变组织病理学是在首次阴道镜检查时发现的,这表明在最初巴氏涂片时可能就已存在高级别发育异常。
报告ASC-H和LSIL-H的巴氏涂片预测高级别鳞状上皮内病变的准确性相似。由于约40%的LSIL-H巴氏涂片患者存在并发或后续的高级别宫颈病变,我们还建议对该组患者立即转诊至阴道镜检查。